Navigo Proteins discovers and develops novel scaffold proteins-based affinity ligands for commercial biologics GMP purification or as biopharmaceutical drugs/binders. They are all small, stable, highly engineerable, selective, and economically, homogeneously producible.
In PRECISION CAPTURING a protein A-like scaffold serves for an antibody-like capture step even of non-Fc bearing molecules.
In PRECISION TARGETING human ubiquitin is the basis for highly selective Affilin® ligands as part of a broad range of biopharmaceutical drugs.
Navigo Proteins’ unique protein engineering expertise is the basis a world-wide unique, versatile scaffold proteins platform. Our robust, rapid and reliable high-throughput-based, robotics assisted platform designs, produces, analyzes and selects suitable affinity ligand proteins, optimized for their tasks in industrial downstream processing or as biopharmaceutical drugs.
PRECISION CAPTURING creates custom ligands against any biologic, Fc-independent, and enables antibody-like affinity downstream processes, with competitive binding capacities, caustic stabilities, usage-cycles, flow rates and commercially available off-the-shelf leaching assays. It is applicable for purifying any recombinant protein, mAb, virus, VLP, cell, etc.
Navigo Proteins has established partnerships with Repligen Corp. to convert its custom affinity ligands into ready-to-use, GMP-compliant affinity resins for commercial downstream processing.
Our PRECISION TARGETING platform creates tailored ligands which bind any desired biologic in biopharmaceutical or in diagnostic use, e.g. radiopharmaceuticals, Protein-drug-conjugates, CAR-T ligands or theranostics, in which the same Affilin® binder is employed in diagnosis, treatment and treatment-monitoring.
Navigo Proteins is about 50 heads strong, steadily growing and based in Halle, S/W of Berlin. We offer our expertise to interested pharma, biotech and life sciences companies.
https://www.navigo-proteins.com/imprint
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2017
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Navigo Proteins GmbH founded?
Navigo Proteins GmbH was founded in 2017.
What industry is Navigo Proteins GmbH in?
Navigo Proteins GmbH operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Navigo Proteins GmbH based?
Navigo Proteins GmbH is headquartered in Halle/Saale, Germany.
Find investors for your startup like Navigo Proteins GmbH
Gritt sends AI-personalised outreach to each investor — from your Gmail